Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elan product launches

Executive Summary

Elan affiliate O'Brien Pharmaceuticals has launched two enteral nutritional products, Reabilan and Reabilan HN in the U.S. and Canada. Elan acquired U.S. and Canadian marketing rights to the Reabilan product line from Roussel-Uclaf. In November Elan announced its purchase of a 27% equity interest in O'Brien with the option to increase its total equity to approximately 60% ("The Pink Sheet" Nov. 17, In Brief). Reabilan and future nutritional products will be supplied by the newly-created joint venture Elan Roussel Nutrition.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS011425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel